213 related articles for article (PubMed ID: 28935468)
1. Function and regulation of LAG3 on CD4
Ma QY; Huang DY; Zhang HJ; Wang S; Chen XF
Exp Cell Res; 2017 Nov; 360(2):358-364. PubMed ID: 28935468
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of LAG3 and TIM3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients.
Ma Q; Liu J; Wu G; Teng M; Wang S; Cui M; Li Y
Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1002-1009. PubMed ID: 29905955
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2.
Okamura T; Fujio K; Shibuya M; Sumitomo S; Shoda H; Sakaguchi S; Yamamoto K
Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13974-9. PubMed ID: 19666526
[TBL] [Abstract][Full Text] [Related]
4. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
5. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
7. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
[TBL] [Abstract][Full Text] [Related]
8. Elevated Circulating CD4
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
[No Abstract] [Full Text] [Related]
9. Relationship between CD4+CD25+ Treg and expression of HIF-1α and Ki-67 in NSCLC patients.
He LY; Li L; Guo ML; Zhang Y; Zhang HZ
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1351-5. PubMed ID: 25967708
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
[TBL] [Abstract][Full Text] [Related]
11. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
[TBL] [Abstract][Full Text] [Related]
12. Identification of tonsillar CD4
Sumitomo S; Nakachi S; Okamura T; Tsuchida Y; Kato R; Shoda H; Furukawa A; Kitahara N; Kondo K; Yamasoba T; Yamamoto K; Fujio K
J Autoimmun; 2017 Jan; 76():75-84. PubMed ID: 27653378
[TBL] [Abstract][Full Text] [Related]
13. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
[TBL] [Abstract][Full Text] [Related]
14. CD25-expressing Th17 cells mediate CD8
Lang C; Wang J; Chen L
Exp Cell Res; 2017 Nov; 360(2):384-389. PubMed ID: 28942020
[TBL] [Abstract][Full Text] [Related]
15. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
16. TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses.
Okamura T; Sumitomo S; Morita K; Iwasaki Y; Inoue M; Nakachi S; Komai T; Shoda H; Miyazaki J; Fujio K; Yamamoto K
Nat Commun; 2015 Feb; 6():6329. PubMed ID: 25695838
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
Ganesan AP; Johansson M; Ruffell B; Yagui-Beltrán A; Lau J; Jablons DM; Coussens LM
J Immunol; 2013 Aug; 191(4):2009-17. PubMed ID: 23851682
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
19. CD69+ CD4+ CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1.
Han Y; Guo Q; Zhang M; Chen Z; Cao X
J Immunol; 2009 Jan; 182(1):111-20. PubMed ID: 19109141
[TBL] [Abstract][Full Text] [Related]
20. CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients.
Ju S; Qiu H; Zhou X; Zhu B; Lv X; Huang X; Li J; Zhang Y; Liu L; Ge Y; Johnson DE; Ju S; Shu Y
Cell Cycle; 2009 Aug; 8(16):2578-85. PubMed ID: 19597336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
